SGP
SpyGlass Pharma, Inc. Common Stock • NASDAQ
$25.03 ▲ 1.21% (+0.30)
SGP
SpyGlass Pharma, Inc. Common StockNASDAQ • $25.03 ▲ 1.21% (+0.30)
Market Cap $836.67 M
52w High $32.44
52w Low $20.15
P/E -20.02
Volume 22.04K
Outstanding Shares 33.43M
Market Cap $836.67 M
52w High $32.44
52w Low $20.15
P/E -20.02
Volume 22.04K
Outstanding Shares 33.43M
About SpyGlass Pharma, Inc. Common Stock
http://www.spyglasspharma.comSpyGlass Pharma, Inc. is a late-stage biopharmaceutical, which engages in the development of treatment paradigm for patients living with chronic eye conditions.
CEO
Patrick Mooney
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Biotechnology
Sector Healthcare
Went public January 8, 2008
Method of going public IPO
Full time employees 1,489
JUN
8 MON
Upcoming Earnings
Date Jun 8, 2026
Day Monday
Revenue Est. —
ETFs Holding This Stock
Summary
Total 32
Showing Top 3 of 32
Price Target
Target High $62
Target Low $62
Target Median $62
Target Consensus $62